Literature DB >> 14711882

Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients.

Duygu Selcen1, Kinji Ohno, Andrew G Engel.   

Abstract

The term myofibrillar myopathy (MFM) was proposed in 1996 as a non-committal term for a pathological pattern of myofibrillar dissolution associated with accumulation of myofibrillar degradation products and ectopic expression of multiple proteins that include desmin, alphaB-crystallin (alphaBC), dystrophin and congophilic amyloid material. Subsequent studies revealed dominant mutations in desmin and alphaBC in some MFM patients, and clinical differences between kinships. We here review the clinical, structural and genetic features of 63 unrelated patients diagnosed as having MFM at the Mayo Clinic between 1977 and 2003. The age of onset was 54 +/- 16 years (mean +/- SD). Weakness was both proximal and distal in 77% and proximal only in 13%. Cardiomyopathy was diagnosed in 16%. Electro myography revealed a myopathic pattern associated with abnormal electrical irritability; 13 patients had abnormal nerve conduction studies but four of these had long-standing diabetes. The abnormal muscle fibres are best identified in trichrome-stained sections as harbouring amorphous, granular or pleomorphic hyaline structures, and vacuoles containing membranous material. The hyaline structures are strongly congophilic. Semiquantitative analysis in each case indicates that among the abnormal fibres, an average of 90, 75, 75, 70 and 70% abnormally express myotilin, desmin, alphaBC, dystrophin and beta-amyloid precursor protein, respectively. Therefore, immunostains for these proteins, and especially for myotilin, are useful adjuncts in the diagnosis of MFM. Electron microscopy shows progressive myofibrillar degeneration commencing at the Z-disk, accumulation of degraded filamentous material and entrapment of dislocated membranous organelles in autophagic vacuoles. In all patients, we searched for mutations in desmin and alphaBC, as well as in telethonin, a Z-disk-associated protein, or in syncoilin, which together with plectin links desmin to the Z-disk. Two of the 63 patients carry truncation mutations in the C-terminal domain of alphaBC, four carry missense mutations in the head or tail region of desmin, and none carries a mutation in syncoilin or telethonin. Thus, MFM is morphologically distinct but genetically heterogeneous. Further advances in defining the molecular causes of MFM will probably come from linkage studies of informative kinships or from systematic search for mutations in proteins participating in the intricate network supporting the Z-disk.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14711882     DOI: 10.1093/brain/awh052

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  58 in total

1.  Disease mutations in the "head" domain of the extra-sarcomeric protein desmin distinctly alter its assembly and network-forming properties.

Authors:  Sarika Sharma; Norbert Mücke; Hugo A Katus; Harald Herrmann; Harald Bär
Journal:  J Mol Med (Berl)       Date:  2009-09-08       Impact factor: 4.599

2.  Post-translationally modified human lens crystallin fragments show aggregation in vitro.

Authors:  O P Srivastava; K Srivastava; J M Chaves; A K Gill
Journal:  Biochem Biophys Rep       Date:  2017-02-20

Review 3.  As time flies by: Investigating cardiac aging in the short-lived Drosophila model.

Authors:  Anna C Blice-Baum; Maria Clara Guida; Paul S Hartley; Peter D Adams; Rolf Bodmer; Anthony Cammarato
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-11-27       Impact factor: 5.187

4.  Clinical and myopathological characteristics of desminopathy caused by a mutation in desmin tail domain.

Authors:  Paul Maddison; Maxwell S Damian; Caroline Sewry; Catherine McGorrian; John B Winer; Zagaa Odgerel; Alexey Shatunov; Hee Suk Lee; Lev G Goldfarb
Journal:  Eur Neurol       Date:  2012-10-05       Impact factor: 1.710

5.  Clinical, pathological, and genetic mutation analysis of sporadic inclusion body myositis in Japanese people.

Authors:  Huaying Cai; Ichiro Yabe; Kazunori Sato; Takahiro Kano; Masakazu Nakamura; Hideki Hozen; Hidenao Sasaki
Journal:  J Neurol       Date:  2012-02-17       Impact factor: 4.849

6.  When myopathy breaks the rules: a late-onset distal presentation.

Authors:  Rachel Newby; Stuart Jamieson; Bjarne Udd; Jane Alty
Journal:  BMJ Case Rep       Date:  2015-04-24

7.  Target genes of neuron-restrictive silencer factor are abnormally up-regulated in human myotilinopathy.

Authors:  Marta Barrachina; Jesús Moreno; Salvador Juvés; Dolores Moreno; Montse Olivé; Isidre Ferrer
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

8.  Intermediate filament diseases: desminopathy.

Authors:  Lev G Goldfarb; Montse Olivé; Patrick Vicart; Hans H Goebel
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

Review 9.  Myofibrillar myopathies.

Authors:  Duygu Selcen
Journal:  Curr Opin Neurol       Date:  2008-10       Impact factor: 5.710

10.  Maintenance of muscle mass, fiber size, and contractile function in mice lacking the Z-disc protein myotilin.

Authors:  Julien Ochala; Olli Carpén; Lars Larsson
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.